Rosita-2 project Final Report Editors: Alain G. Verstraete Elke Raes Grant agreement n°SUB-B27020B-E3-S07.18222-2002 Final Report March 2006 Ghent University Department of Clinical Biology, Microbiology and Immunology De Pintelaan 185 9000 Gent Belgium E-mail:
[email protected] 1 Contents Chapter 1 Executive Summary 4 Chapter 2 Introduction 7 Chapter 3 Survey of existing POCT tests 11 Chapter 4 Results from Belgium 32 Chapter 5 Results from Finland 46 Chapter 6 Results from Germany 81 Chapter 7 Results from Norway 95 Chapter 8 Results from Spain 111 Overview of Rosita-2 US operations 129 Chapter 9 Results from the USA: Florida 132 Chapter 10 Results from the USA: Utah 144 Chapter 11 Results from the USA: Washington 156 Chapter 12 Results from the USA: Wisconsin 170 Chapter 13 Global results 189 Chapter 1 Executive summary. • The Rosita-2 project was carried out in 2003-2005 in order to evaluate the usability and analytical reliability of the onsite oral fluid (saliva) drug testing devices. • The study was carried out by National Institute for Criminalistics and Criminology in Brussels, Belgium, the National Public Health Institute in Helsinki, Finland, the Institute for Legal Medicine in Strasbourg, France, the Institute for Legal Medicine in Homburg/Saar, Germany, the Division of Forensic Toxicology and Drug Abuse, Norwegian Institute of Public Health, Oslo, Norway and Institute of Legal Medicine, University of Santiago de Compostela, Spain. It was coordinated by Ghent University, Ghent, Belgium. • The study was performed in cooperation with the Unites States, where it is funded by The National Institute on Drug Abuse (NIDA), National Institutes of Health, US Department of Health and Human Services, the National Highway Traffic Safety Administration (NHTSA), US Department of Transportation and the Office of National Drug Control Policy Executive Office of the President.